These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9248123)

  • 1. Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
    Yen DJ; Yiu CH; Kwan SY; Lin YY; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 May; 59(5):303-7. PubMed ID: 9248123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
    N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study.
    Chen SJ; Chang KP; Wong TT; Kwan SY; Hsu ML; Wang CC
    Acta Paediatr Taiwan; 2006; 47(3):123-6. PubMed ID: 17078464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
    Donaldson JA; Glauser TA; Olberding LS
    Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
    Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG.
    Bisulli F; Baruzzi A; Rosati A; Riva R; Avoni P; Cerullo A; Tinuper P
    Epileptic Disord; 2001 Sep; 3(3):151-6. PubMed ID: 11679308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine therapy of epilepsy in tuberous sclerosis.
    Franz DN; Tudor C; Leonard J; Egelhoff JC; Byars A; Valerius K; Sethuraman G
    Epilepsia; 2001 Jul; 42(7):935-40. PubMed ID: 11488895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lamotrigine in add-on therapy: assessment of efficacy in drug resistant epilepsy].
    Juryńczyk J; Weglewski A
    Neurol Neurochir Pol; 2000; 34(1):43-7. PubMed ID: 10849903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.